ACTO

JUNE 29, 2023

Todd Amrhein Award-winning Director of Global Training, Learning and Development, Marketing, and Sales About Todd Amrhein : Todd is a results-driven, award-winning Director of Global Training, Learning and Development, Marketing, and Sales in the biotechnology and pharmaceutical industry.

International 52

International Marketing Production Science 52

ACTO

JUNE 28, 2023

To achieve successful behavior change over time and impact performance, a pre-launch measurement strategy and post-launch alignment between sales, marketing, and CL&D teams were identified as critical success factors. Measurement techniques discussed included: Certifications at launch or immediately after.

Production 52

Production Science International Marketing 52

Perficient: Drug Development

JUNE 12, 2024

The Salesforce MuleSoft Meetup: This meetup was a Salesforce MuleSoft Joint Community In-Person Meetup organized by the Salesforce Marketing Group and Nagpur MuleSoft Meetup Group in partnership with Perficient India at Perficient GDC Nagpur Campus. Following this, I conducted a demo on how to create an Einstein Bot in Salesforce Org.

Marketing 40

Marketing Production 40

Perficient: Drug Development

JUNE 8, 2023

Robert Sumner, Perficient Adobe Consulting Principal, praised Adobe’s approach noting how the integration of the latest Next Generation Composability Content Management product strengthens Adobe’s positioning in the market. Robert Sumner gave a detailed demo of Adobe’s Next Generation Composability product (NGC).

Production 52

Production Marketing 52

H1 Blog

NOVEMBER 6, 2023

By utilizing a single healthcare data platform that allows for seamless information sharing between teams, medical affairs can gain access to valuable market insights from the commercial team while also being able to provide feedback on HCP engagement to support sales efforts–all supported with real-world, structured data insights.

Marketing 64

Marketing International Science Treatment 64

Perficient: Drug Development

FEBRUARY 27, 2024

Imagine this: You are a marketer at a medical device organization. It’s every marketer’s dream. Let’s look at a few ways medical device marketers can supercharge the digital product catalogs. If not, your product page will benefit from a shot of interactivity. Think about your last demo or trade show.

Production 52

Production Testimonials Marketing Science 52

Perficient: Drug Development

AUGUST 7, 2023

We are excited to introduce a revolutionary visual modeling tool that empowers marketers to effortlessly design and implement personalized customer journeys, without the need for extensive programming knowledge. Easily define stages and actions to construct the decision-making process that aligns with your marketing goals.

Marketing 52

Marketing 52

H1 Blog

JULY 30, 2024

This crucial inclusion of diverse populations through enrollment accuracy creates a direct correlation to operational efficiency, allowing for a quicker go-to-market process, a reduction in costly mistakes, and a more robust alignment to overall FDA requirements. Find out more by requesting a demo today.

FDA 59

FDA Clinical Trials Compliance Pharma Companies 59

ACTO

MAY 7, 2024

While reps are trained on new marketing content, it is hard for them to remember the talking points in the moment of need. ET at the Veeva Commercial Summit in Boston to learn more and see a demo. With TalkTRx, reps can pull up the approved asset from Vault PromoMats on ACTO and review the key message points in a matter of minutes.

Science 52

Science Production Marketing 52

H1 Blog

MARCH 28, 2023

In fact, the global medical devices market is projected to grow from $495.46 Understanding and incorporating the payer perspective and data requirements early in product development is essential in this increasingly cost-conscious market. To learn more about Carevoyance, H1’s Claims Intelligence Solution, request a demo.

Production 52

Production Marketing Treatment Hospitals 52

Perficient: Drug Development

SEPTEMBER 11, 2024

Thousands of brands, marketers, technologists, and digital visionaries come together for three days of top-notch networking, inspiring success stories, innovation-driven sessions, and more. Sitecore Symposium is Sitecore’s biggest event of the year. General conference passes start at $1,849 and will be raised to $2,049 starting October 1.

Compliance 52

Compliance Engineering Production Marketing 52

Perficient: Drug Development

DECEMBER 21, 2023

This is a feature that some other market-leading headless CMS’s have today and I’m not surprised as a possible use case. The product team at Sitecore is still testing this capability and considering if they want to provide this level of control to customers.

Production 52

Production Marketing 52

H1 Blog

DECEMBER 11, 2024

While this approach aims to improve ROI before potential price controls kick in, it complicates trial design and recruitment, increasing the time it takes to get treatments to market. The downstream impacts of the IRA will lead to fewer new drugs entering the market, limiting treatment options for patients.

Clinical Trials 52

Clinical Trials Trials Pharma Companies Treatment 52

H1 Blog

JULY 5, 2023

From trial site feasibility to successful trial recruitment, diversity within a trial population helps ensure the safety and efficacy of drugs that reach the market. To learn more about how H1 can help diversify your HCP engagement strategy, request a demo.

Clinical Trials 52

Clinical Trials Drugs Trials Drug Development 52

Perficient: Drug Development

SEPTEMBER 29, 2023

I previously wrote about Sitecore Content Hub ONE and its place in the market as a new pure play headless CMS. image source: [link] Sitecore Pano – manage virtual experiences in Content Hub ONE Sitecore Pano is demo of a virtual world-like experience using a panoramic library and Content Hub ONE to source content.

Hospitals 52

Hospitals Marketing 52

H1 Blog

JULY 24, 2023

Strategies for Market Access Teams One thing the healthcare ecosystem lacks in the United States is a system of shareable, actionable healthcare data. For more information about understanding payer and patient utilization trends, request a demo. So where is one possible place pharma can look for insights into patients?

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceuticals Treatment Pharmacy 52

H1 Blog

JUNE 8, 2023

This not only ensures overall safety but also creates opportunities for better access equity throughout different regions and markets worldwide. To learn more about how H1 can empower medical affairs teams to diversity KOLs and HCPs leveraging H1’s HCP Universe , request a demo.

Drug Development 52

Drug Development Science Pharmaceutical Companies Production 52

Perficient: Drug Development

NOVEMBER 6, 2023

I wanted a smaller amount for the demo, so I created two connections with a limit parameter to allow me to configure how many results I wanted back. This could incorporate a decision table to allow marketers to more easily configure it, or even my decision modelling tool to make the selection process easier to conceptualize.

Production 52

Production Marketing 52

Perficient: Drug Development

AUGUST 23, 2023

Content Hub ONE is Sitecore’s entry into the pure play headless CMS market. For years this market was dominated by well-known players such as Contentful, Kontent.ai, Contentstack, Sanity, and Strapi. You may be thinking that sounds contrary to what we preach: “put as much control as possible in marketers’ hands!”

Marketing 52

Marketing Production 52

Perficient: Drug Development

JANUARY 3, 2024

Here are the top 7 reasons this should be the case: XM Cloud Empowers Marketers to Create their own Components and Get Started with Personalization XM Cloud provides a brand-new WYSIWYG component building experience to marketers, who can lay out their components however they want and use them directly in pages.

Compliance 52

Compliance Marketing Production Licensing 52

H1 Blog

SEPTEMBER 26, 2023

Use Case: Label Expansion in a New Market When evaluating prospective sites for a clinical trial, it’s important to consider the following factors: location (both in and outside of the U.S.), Request a demo of Trial Landscape. size and expertise of staff, patient demographics, infrastructure and access to specialized technology.

Trials 59

Trials Clinical Trials International Regulations 59

Perficient: Drug Development

DECEMBER 4, 2023

Our “Six Pack” includes: Strategy & Transformation, Customer Experience & Digital Marketing, Innovation & Product Development, Platforms & Technology and Data & Intelligence. ” You can view the recorded demo here.

Engineering 52

Engineering Production Marketing 52

H1 Blog

JUNE 7, 2023

This data will be invaluable in identifying potential contacts for marketing efforts, allowing the Foundation to effectively reach out to physicians who are most likely to be interested in their initiatives.

Trials 52

Trials Clinical Trials Pharma Companies Clinical Development 52

Perficient: Drug Development

OCTOBER 11, 2023

Most marketing teams have finite resources, so it’s our job to build an onramp that makes the road to personalization accessible, achievable, and maintainable – no matter where they’re starting. Yet many organizations have been hesitant to make the leap because a platform this powerful can also be complex.

Production 59

Production Marketing Hospitals International 59

Practical Cheminformatics

JANUARY 8, 2024

Aside from some very brief demos on code generation and literature searches, mentions of LLM applications in preclinical research were scarce. The authors provided examples where GPT-4 could provide a SMILES string, IUPAC name, or descriptive text for a marketed drug. Most of the drug discovery examples were underwhelming.

Drugs 139

Drugs Small Molecule Bioinformatics Packaging 139

sptlabtech

DECEMBER 2, 2022

These were the benefits most popular with many customers who were treated to tailored firefly demos at the various locations on the international tour. We've seen the cost of sequencing continually go down with new sequencing platforms coming onto the market. Feedback from customers has been consistently good from all quarters.

International 52

International Laboratories Research Marketing 52

Perficient: Drug Development

JANUARY 10, 2024

Here’s an example of a follow up question after getting the initial list of keywords: Code Generation Applications Besides proving context for content/marketing related applications, the other major use case I wanted to build this integration for was to support code generation.

Engineering 52

Engineering International Marketing 52

Codon

MAY 30, 2023

He took products to market at prices people were willing to pay. The demos are this Sunday, June 4th! Read An excellent essay about Thomas Edison, and why he was brilliant despite the criticisms. “He took tech that barely worked and made it useful. He made things that could be manufactured at scale. He hit deadlines.”

DNA 52

DNA RNA Engineering Vaccine 52

Codon

MAY 30, 2023

He took products to market at prices people were willing to pay. The demos are this Sunday, June 4th! Read An excellent essay about Thomas Edison, and why he was brilliant despite the criticisms. “He took tech that barely worked and made it useful. He made things that could be manufactured at scale. He hit deadlines.”

DNA 52

DNA RNA Engineering Vaccine 52

Agency IQ

MAY 31, 2024

and 2 mg [EMA] Product-specific bioequivalence guidance 6/30/2024 Pharmeuropa 36.2

Regulations 40

Regulations Production Compliance Pharmaceuticals 40

The Pharma Data

MAY 14, 2021

You can’t learn these “forbidden” exercises from some internet copy of an ancient ninja scroll some “collector” got off the black market. The “lecture”, explanations and demos are invaluable, with enough material to keep anyone busy for some time. Anyway, that’s NOT what this is about. How do you come up with this stuff…?”

Packaging 52

Packaging Production Vaccine International 52

H1 Blog

DECEMBER 18, 2023

DOLs will also increasingly turn back to in-person interactions, conferences, public speaking, and other direct means to voice their opinions and establish a more credible presence, moving away from digital platforms.” – Alexandra Moens, Senior Director of Product Marketing 4.

Trials 64

Trials Clinical Trials FDA Pharmaceutical Companies 64

Agency IQ

DECEMBER 1, 2023

Expected Action Description of action Date Eudamed Module: Market Surveillance [E.U.] Completed development of the EUDAMED Market Surveillance module Q4 2023 Designation of E.U. Expected Action Description of action Original Deadline Pharmaceuticals – changes to marketing authorisations (review of EU rules) [E.U.]

Regulations 40

Regulations Clinical Trials Production Biosimilars 40

H1 Blog

NOVEMBER 29, 2023

Every day, patients around the globe are waiting for life-saving treatments to reach the market. One major obstacle stands in the way of getting potentially life-saving treatments to market faster – data silos. To learn more, request a demo.

Clinical Trials 59

Clinical Trials Trials Drug Development Treatment 59

Agency IQ

MARCH 29, 2024

April 2024 Market-Based Approaches Under the National Pollutant Discharge Elimination System (NPDES) Program (Proposed Rule Stage) 2040-AG02 EPA supports market-based mechanisms, including water quality trading under the Clean Water Act (CWA). EPA plans to continue its outreach efforts with affected parties.

Regulations 40

Regulations Compliance Production Government 40

Perficient: Drug Development

DECEMBER 23, 2024

A Showcase of Innovation: Live Demo One of the events highlights was the live demo by Abishek Surendrababu, who provided a hands-on walkthrough of BrowserStacks versatile features. Engaging Discussions and Interactive Q&A The live demo seamlessly transitioned into an interactive Q&A session.

Engineering 52

Engineering Production Marketing 52

H1 Blog

JANUARY 16, 2025

We are excited for what this means for our customers and the market, for our employees, and for our investors. If you want to learn more, request a demo. Services will continue without interruption, and were dedicated to maintaining quality and support while delivering even greater value to all stakeholders Whats Next?

Pharmaceutical Companies 52

Pharmaceutical Companies Doctors Pharmaceuticals Production 52